The Signaling Effects of Stacked FDA Designations

Time

Mon, Jun 15 9:30AM
M 10

Title

The Signaling Effects of Stacked FDA Designations

Abstract Summary

An event study methodology was used to determine whether investors believed that the announcement of a drug designation provided information regarding the drug, by analyzing the stock price of companies after the announcement using the market model.

Poster Presenter

Kathleen Miller
PhD, MS,
Doctoral Student ,
University of North Carolina at Chapel Hill
United States